EU Proposals On R&D Funding Transparency Could Increase Pressure On Companies Negotiating Drug Prices
Executive Summary
The draft Directive that was published last month with a draft Regulation for reforming the EU’s medicines legislation includes proposals for companies to publicly declare financial support received from a public authority or publicly funded body for R&D activities.